Alpha Modus (AMOD) Sues Walgreens for Patent Infringement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation
February 4, 2025 8:00 AM ESTCORNELIUS, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (Company) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (Alpha Modus), has filed a patent infringement lawsuit that also alleges willful infringement against Walgreens Co. (Walgreens) in the United States District Court for the Eastern District of Texas. This legal action underscores Alpha Moduss unwavering commitment to protecting its groundbreaking AI-driven retail technology and further solidifies its leadership in the rapidly evolving retail innovation landscape.
Championing Innovation and Protecting Shareholder Value
Alpha Modus has transformed AI-powered retail engagement... More



